Here's why IPCA Laboratories would be a hot favourite among investors this year too
Updated : January 14, 2020 02:04 PM IST
In the calendar year 2019-20, the Nifty Pharma index was down 9 percent after the losses in heavyweights like Sun Pharma, Glenmark, Cipla and Biocon amongst others.
IPCA Laboratories climbed 92 percent in CY19 and has already risen 8.53 percent this year in 10 trading sessions.
The active pharmaceutical ingredient seller stood as the best-performing mid-sized pharma stock of 2019.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more